CereVasc, Inc., a clinical-stage medical device company developing novel, minimally invasive treatments for neurological ...

The outcomes are intended to form the clinical basis for CereVasc’s PMA submission to the FDA.

To explore techniques, advantages and disadvantages of 3D Slicer reconstruction and 3D printing localization technology combined with transcranial neuroendoscopy in ventriculoperitoneal shunt surgery.

Hydrocephalus, commonly known as fluid or water on the brain, can occur in the womb or be caused by hemorrhage, tumors, trauma or infection. The "water" in this case is an excess of cerebrospinal ...

CereVasc, Inc. announced it has completed patient enrollment in the STRIDE pivotal trial, which is evaluating the company’s ...